Published in
American Society of Hematology, Blood, 24(129), p. 3227-3236, 2017
DOI: 10.1182/blood-2017-01-761999
Links
Tools
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis
Journal article published in 2017 by
Paola Guglielmelli 
,
Annalisa Pacilli,
Giada Rotunno,
Elisa Rumi,
Vittorio Rosti,
Federica Delaini,
Margherita Maffioli,
Tiziana Fanelli,
Alessandro Pancrazzi,
Daniela Pietra,
Silvia Salmoiraghi,
Carmela Mannarelli,
Annalisa Franci,
Chiara Paoli,
Alessandro Rambaldi
and other authors.
,
Annalisa Pacilli,
Giada Rotunno,
Elisa Rumi,
Vittorio Rosti,
Federica Delaini,
Margherita Maffioli,
Tiziana Fanelli,
Alessandro Pancrazzi,
Daniela Pietra,
Silvia Salmoiraghi,
Carmela Mannarelli,
Annalisa Franci,
Chiara Paoli,
Alessandro Rambaldi
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points Differential diagnosis of pre-PMF and overt PMF by 2016 WHO criteria underscores uniqueness in disease presentation and outcome. Patterns of driver and nondriver myeloid gene mutations contribute to prognosis in both pre-PMF and overt PMF.